Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy

Documenti analoghi

• A national survey on the impact of the coronavirus pandemic on gynecologic surgical training
  di: Daniel Galvin, et al.
  Pubblicazione: (2024)
• Pharmacological treatment of ectopic pregnancy: Accuracy, safety and cost‐effectiveness of day 1–7 β‐hCG measurements
  di: Adi Dayan‐Schwartz, et al.
  Pubblicazione: (2024)
• Response: Pharmacological treatment of ectopic pregnancy: Accuracy, safety and cost‐effectiveness of day 1–7 β‐hCG measurements
  di: Adi Dayan‐Schwartz
  Pubblicazione: (2024)
• Reproductive Outcomes of Dual Trigger versus hCG Alone in Women Undergoing In Vitro Fertilization with Fresh Embryo Transfer Cycles
  di: Fatma Ceren Guner, et al.
  Pubblicazione: (2024)
• Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation
  di: Caroline E. Fox, et al.
  Pubblicazione: (2025)